Literature DB >> 10994446

Refraction and accommodation in diabetic school children.

M Mäntyjärvi1, I Nousiainen.   

Abstract

Refraction and accommodation of 61 diabetic children (aged 9 to 16 years) and 92 non-diabetic children (aged 10 to 16 years) were studied. Myopia was found in 36.1% of the diabetic children and in 29.3% of the non-diabetic children. The difference was not statistically significant. In the diabetic children, the age of the onset of myopia and the progression of myopia were the same as in the usual myopia at school age. The refraction curve of the diabetic children was less peaked than that of the non-diabetic children; a greater number of low myopic refractions were observed, and the low hyperopic refractions were more evenly distributed in the curve of the diabetic children. The mean accommodation of the diabetic children was 9.9 D +/- 2.2, and in the non-diabetic children it was 11.8 D +/- 2.6. The difference was statistically significant. The accommodation of both the diabetic and non-diabetic girls was lower than that of the boys. The accommodation in the myopic diabetic children was statistically significantly lower than the accommodation in the hyperopic diabetic children.

Entities:  

Mesh:

Year:  1988        PMID: 10994446     DOI: 10.1111/j.1755-3768.1988.tb04595.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  3 in total

1.  Myopia in young patients with type 1 diabetes mellitus.

Authors:  Swati Handa; Audrey Chia; Hla Myint Htoon; Pin Min Lam; Fabian Yap; Yvonne Ling
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

Review 2.  Clinical and laboratory investigations of the relationship of accommodation and convergence function with refractive error. A literature review.

Authors:  D A Goss; H Zhai
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Ocular findings in prematurely born children at 5 years of age.

Authors:  K Tuppurainen; E Herrgård; A Martikainen; M Mäntyjärvi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.